Am Law 100 firm Polsinelli continues growing its nationwide Intellectual Property Department with the addition of Timothy M. Schaum as a shareholder in the Intellectual Property Litigation Practice. Joining Polsinelli in Chicago, Schaum’s practice focuses on a wide array of disputes, including intellectual property issues, breach of contract and price-fixing allegations.

“We are excited to welcome Tim to our IP Litigation Practice. His ability to manage complex IP disputes enhances our team’s ability to deliver exceptional outcomes for our clients,” said Intellectual Property Litigation Chair Michael D. Pegues.

“I chose Polsinelli for one reason: the people,” Schaum says. “This is a firm where people matter, culture matters, and a hand-shake deal still matters. I know at Polsinelli this is a firm that backs its clients, has exceptional lawyers in all fields, and can handle all aspects of a client’s business,” he added.

Tim Schaum received his B.A. at Hendrix College before completing his J.D. at the Washington University School of Law. His clients cover a wide range of U.S.-based manufacturers and industries, including automotive and automotive aftermarket and pharmaceutical. He has extensive experience in both bench and jury trials and has successfully represented clients in complex civil litigation matters. He has also handled numerous appellate cases, advocating before the Seventh Circuit and Federal Circuit Courts of Appeals and is an admitted member of the Eastern District of Michigan.

Schaum’s addition comes on the heels of Zachary Block in St. Louis and Chad Landmon in Washington, D.C., both in the IP department as well.

Polsinelli’s Intellectual Property Department ranks nationally in Tier 1 for Patent Law, Trademark Law and Litigation – Intellectual Property in the 2024 “Best Law Firms®” list by Best Lawyers®. As one of the largest IP practices in the nation, Polsinelli has a deep bench of attorneys, patent agents, scientists and other professionals who oversee some of the most complex issues facing technology and high-tech companies, bioscience and life sciences companies, animal science, medical device, pharmaceutical, chemical, software and business methods.